In diabetes, although ROS-mediated inactivation of NO has been suggested as the key mechanism behind the decreased bioavailability of eNOS-derived NO [251,252], other relevant mechanisms involved in the direct changes in eNOS function and molecular integrity have also been proposed [253]. The gene discussed is NOS3; the disease is diabetes mellitus.